ACP
AEHR icon

Acuta Capital Partners’s Aehr Test Systems AEHR Stock Holding History

Acuta Capital Partners’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-122,000
Closed -$587K – 62
2017
Q1 		$587K Buy
+122,000
New +$459K 0.14% 59

Other funds holding AEHR

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
SC
Shellback Capital Boston, Massachusetts $703M AUM 53.29% 1-Year Est. Return
HIM
Herald Investment Management London, United Kingdom $718M AUM 91.16% 1-Year Est. Return

Acuta Capital Partners's AEHR Position: Q2 2017 in Review

Acuta Capital Partners sold out of Aehr Test Systems (AEHR) in Q2 2017, closing a stake of 122,000 shares — an estimated $587K sold.

Acuta Capital Partners first reported a position in AEHR in Q1 2017 and held it in 1 quarter. The position peaked at $587K in Q1 2017. 22 funds tracked by Wall St. Rank hold AEHR as of Q2 2017.

  • Acuta Capital Partners reported no remaining Aehr Test Systems position as of Q2 2017 after selling out during the quarter.
  • Acuta Capital Partners sold 122,000 Aehr Test Systems shares in Q2 2017, an estimated $587K.
  • Acuta Capital Partners first reported a position in Aehr Test Systems in Q1 2017 and held it in 1 quarter.
  • Acuta Capital Partners's Aehr Test Systems position peaked at $587K in Q1 2017.
  • 22 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2017.

Based on Acuta Capital Partners's 13F filing for Q2 2017, filed 14 Aug 2017.